Quantinno Capital Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13M Buy
166,566
+28,019
+20% +$1.91M 0.02% 880
2026
Q1
$8.95M Buy
138,547
+5,626
+4% +$397K 0.01% 916
2025
Q4
$8.95M Buy
132,921
+96,888
+269% +$6.52M 0.02% 827
2025
Q3
$2.64M Buy
36,033
+23,272
+182% +$1.55M 0.01% 1133
2025
Q2
$664K Buy
12,761
+8,955
+235% +$510K ﹤0.01% 1487
2025
Q1
$243K Buy
+3,806
New +$221K ﹤0.01% 1747

Other funds holding HALO

Quantinno Capital Management's HALO Position: Q2 2026 in Review

Quantinno Capital Management increased its Halozyme (HALO) stake by 20% in Q2 2026, buying an estimated $1.91M and bringing the position to 166,566 shares worth $13M. The position accounts for 0.02% of the portfolio, ranked #880.

Quantinno Capital Management first reported a position in HALO in Q1 2025 and has held it in 6 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Quantinno Capital Management held 166,566 shares of Halozyme worth $13M as of Q2 2026.
  • Quantinno Capital Management bought 28,019 Halozyme shares in Q2 2026, an estimated $1.91M.
  • Halozyme made up 0.02% of Quantinno Capital Management's portfolio in Q2 2026, its #880 holding.
  • Quantinno Capital Management first reported a position in Halozyme in Q1 2025 and has held it in 6 quarters since.
  • 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.